HEADER HYDROLASE 08-FEB-14 4CPT TITLE MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS TITLE 2 ENCOMPASSING A TERTIARY ALCOHOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PR, RETROPEPSIN; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 3 ORGANISM_TAXID: 12721; SOURCE 4 STRAIN: 99HHP1 (D10); SOURCE 5 VARIANT: Z2/CDC-Z34 ISOLATE; SOURCE 6 ATCC: 11676; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VARIANT: AI; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PEXP5 KEYWDS HYDROLASE, HIV-1 PROTEASE, INHIBITOR, RATIONAL DRUG DESIGN, ENZYME EXPDTA X-RAY DIFFRACTION AUTHOR M.DEROSA,J.UNGE,H.V.MOTWANI,A.ROSENQUIST,L.VRANG,H.WALLBERG,M.LARHED REVDAT 3 01-MAY-24 4CPT 1 REMARK SHEET REVDAT 2 17-JAN-18 4CPT 1 REMARK REVDAT 1 17-DEC-14 4CPT 0 JRNL AUTH M.DE ROSA,J.UNGE,H.V.MOTWANI,A.ROSENQUIST,L.VRANG, JRNL AUTH 2 H.WALLBERG,M.LARHED JRNL TITL SYNTHESIS OF P1'-FUNCTIONALIZED MACROCYCLIC TRANSITION-STATE JRNL TITL 2 MIMICKING HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY JRNL TITL 3 ALCOHOL. JRNL REF J.MED.CHEM. V. 57 6444 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25054811 JRNL DOI 10.1021/JM500434Q REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 24849 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1336 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1780 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.2280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 270 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36000 REMARK 3 B22 (A**2) : -0.35000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.099 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.097 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.062 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.872 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1619 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1641 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2207 ; 0.950 ; 2.040 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3783 ; 0.640 ; 3.012 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 205 ; 7.020 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 55 ;40.874 ;24.909 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 283 ;13.259 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;17.416 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 258 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1786 ; 0.016 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 338 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 804 ; 1.324 ; 0.919 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 805 ; 1.323 ; 0.920 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1002 ; 1.926 ; 1.370 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 815 ; 3.281 ; 1.289 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4CPT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1290059703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91000 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26209 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 31.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NON-PUBLISHED REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.08500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.95000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.08500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.95000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2113 O HOH B 2117 1.51 REMARK 500 O HOH B 2011 O HOH B 2047 1.52 REMARK 500 O HOH A 2115 O HOH A 2116 1.58 REMARK 500 O THR B 180 O HOH B 2104 1.62 REMARK 500 O HOH A 2141 O HOH B 2025 1.66 REMARK 500 O HOH B 2015 O HOH B 2016 1.75 REMARK 500 O HOH A 2107 O HOH A 2109 1.75 REMARK 500 O HOH A 2130 O HOH A 2132 1.80 REMARK 500 OD1 ASN A 88 CL CL A 1100 1.80 REMARK 500 O HOH A 2136 O HOH A 2137 1.86 REMARK 500 CG2 THR A 4 O HOH A 2028 1.91 REMARK 500 O HOH A 2012 O HOH B 2110 1.94 REMARK 500 O HOH A 2024 O HOH A 2141 1.95 REMARK 500 O HOH A 2053 O HOH A 2076 1.99 REMARK 500 O HOH B 2018 O HOH B 2110 2.03 REMARK 500 O HOH A 2015 O HOH B 2110 2.05 REMARK 500 O HOH B 2086 O HOH B 2089 2.06 REMARK 500 O HOH A 2094 O HOH A 2095 2.10 REMARK 500 O HOH A 2005 O HOH A 2014 2.12 REMARK 500 O HOH B 2115 O HOH B 2117 2.13 REMARK 500 O HOH A 2008 O HOH A 2025 2.15 REMARK 500 O HOH A 2019 O HOH A 2026 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2082 O HOH B 2098 4455 2.04 REMARK 500 NE2 GLN A 7 O HOH B 2104 4555 2.05 REMARK 500 O HOH A 2110 O HOH A 2110 2665 2.06 REMARK 500 O HOH A 2088 O HOH B 2100 4455 2.13 REMARK 500 O HOH A 2021 O HOH B 2006 4555 2.16 REMARK 500 O HOH A 2109 O HOH A 2117 2665 2.18 REMARK 500 O HOH A 2023 O HOH B 2029 2665 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2111 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH B2118 DISTANCE = 9.59 ANGSTROMS REMARK 525 HOH B2120 DISTANCE = 9.66 ANGSTROMS REMARK 525 HOH B2121 DISTANCE = 8.02 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1T8 B 1202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CPQ RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL REMARK 900 RELATED ID: 4CPR RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL REMARK 900 RELATED ID: 4CPS RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL REMARK 900 RELATED ID: 4CPU RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL REMARK 900 RELATED ID: 4CPW RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL REMARK 900 RELATED ID: 4CPX RELATED DB: PDB REMARK 900 MACROCYCLIC TRANSITION-STATE MIMICKING HIV-1 PROTEASE INHIBITORS REMARK 900 ENCOMPASSING A TERTIARY ALCOHOL DBREF 4CPT A 1 99 UNP P03366 POL_HV1B1 501 599 DBREF 4CPT B 101 199 UNP P03366 POL_HV1B1 501 599 SEQADV 4CPT PRO A 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 4CPT THR A 82 UNP P03366 VAL 582 ENGINEERED MUTATION SEQADV 4CPT VAL A 84 UNP P03366 ILE 584 ENGINEERED MUTATION SEQADV 4CPT PRO B 163 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 4CPT THR B 182 UNP P03366 VAL 582 ENGINEERED MUTATION SEQADV 4CPT VAL B 184 UNP P03366 ILE 584 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO THR ASN VAL ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO THR ASN VAL ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE HET CL A1100 1 HET CL B1200 1 HET CL B1201 1 HET 1T8 B1202 53 HETNAM CL CHLORIDE ION HETNAM 1T8 METHYL [(2S)-1-(2-{3-[(3R,6S,10Z)-3-HYDROXY-4,7-DIOXO- HETNAM 2 1T8 6-(PROPAN-2-YL)-5,8-DIAZABICYCLO[11.2.2]HEPTADECA- HETNAM 3 1T8 1(15),10,13,16-TETRAEN-3-YL]PROPYL}-2-[4-(PYRIDIN-3- HETNAM 4 1T8 YL)BENZYL]HYDRAZINYL)-3,3-DIMETHYL-1-OXOBUTAN-2- HETNAM 5 1T8 YL]CARBAMATE FORMUL 3 CL 3(CL 1-) FORMUL 6 1T8 C41 H54 N6 O6 FORMUL 7 HOH *270(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 186 THR B 191 1 6 SHEET 1 AA 4 GLN A 2 ILE A 3 0 SHEET 2 AA 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3 SHEET 3 AA 4 THR A 96 ASN A 98 -1 O THR A 96 N ASN B 198 SHEET 4 AA 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97 SHEET 1 AB 7 LEU A 10 ILE A 15 0 SHEET 2 AB 7 GLN A 18 LEU A 24 -1 O GLN A 18 N ILE A 15 SHEET 3 AB 7 VAL A 84 ILE A 85 1 N ILE A 85 O LEU A 23 SHEET 4 AB 7 VAL A 32 LEU A 33 -1 O VAL A 32 N VAL A 84 SHEET 5 AB 7 HIS A 69 VAL A 77 1 O LEU A 76 N LEU A 33 SHEET 6 AB 7 GLY A 52 ILE A 66 -1 O ARG A 57 N VAL A 77 SHEET 7 AB 7 LEU A 10 ILE A 15 0 SHEET 1 BA 7 LEU B 110 ILE B 115 0 SHEET 2 BA 7 GLN B 118 LEU B 124 -1 O GLN B 118 N ILE B 115 SHEET 3 BA 7 VAL B 184 ILE B 185 1 N ILE B 185 O LEU B 123 SHEET 4 BA 7 VAL B 132 LEU B 133 -1 O VAL B 132 N VAL B 184 SHEET 5 BA 7 HIS B 169 VAL B 177 1 O LEU B 176 N LEU B 133 SHEET 6 BA 7 GLY B 152 ILE B 166 -1 O ARG B 157 N VAL B 177 SHEET 7 BA 7 LEU B 110 ILE B 115 0 SITE 1 AC1 2 TRP B 106 HOH B2091 SITE 1 AC2 4 THR A 74 ASN A 88 HOH A2127 ARG B 141 SITE 1 AC3 3 THR B 174 ASN B 188 HOH B2106 SITE 1 AC4 20 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC4 20 ASP A 29 GLY A 48 GLY A 49 PRO A 81 SITE 3 AC4 20 THR A 82 HOH A2092 ARG B 108 LEU B 123 SITE 4 AC4 20 ASP B 125 GLY B 127 ALA B 128 ASP B 129 SITE 5 AC4 20 GLY B 148 GLY B 149 PHE B 153 HOH B2084 CRYST1 58.170 85.900 46.360 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017191 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011641 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021570 0.00000